NEW
YORK, Aug. 29, 2024 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of SeaStar
Medical Holding Corporation (NASDAQ: ICU).
Shareholders who purchased shares of ICU during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/seastar-medical-loss-submission-form/?id=98725&from=4
CLASS PERIOD: October 31,
2022 to March 26, 2024
ALLEGATIONS: The complaint alleges that
during the class period, Defendants issued materially false and/or
misleading statements and/or failed to disclose that: (i) SeaStar
and/or Legacy SeaStar had deficient compliance controls and
procedures related to the Humanitarian Device Exemption (HDE)
Application; (ii) accordingly, there were deficiencies with the HDE
Application, the FDA was unlikely to approve the HDE Application in
its present form, and the selective cytopheretic device's
regulatory prospects were overstated; (iii) the Company had
downplayed the true scope and severity of deficiencies in its
financial controls and procedures, while overstating Defendants'
efforts to remediate the same; (iv) accordingly, SeaStar had failed
to properly account for the classification of certain outstanding
warrants and the prepaid forward agreement; (v) as a result,
SeaStar was likely to restate one or more of its previously issued
financial statements; (vi) accordingly, SeaStar's post-merger
business and financial prospects were overstated; and (vii) as a
result, the Company's public statements were materially false and
misleading at all relevant times.
DEADLINE: September 6, 2024
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/seastar-medical-loss-submission-form/?id=98725&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of ICU during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is September 6, 2024. There is no cost or obligation
to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-announces-the-filing-of-a-securities-class-action-on-behalf-of-seastar-medical-holding-corporationicu-shareholders-302233233.html
SOURCE Gross Law Firm